Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3500556013 | Acetaminophen 500 mg and codeine phosphate 30 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3681649016 | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3681651017 | Codeine phosphate 30 mg and paracetamol 500 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
46664501000001112 | Co-codamol 30mg/500mg tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Co-codamol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Non-opioid analgesic | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Acetaminophen + codeine phosphate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Codeine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Codeine phosphate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Central nervous system agent | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Substance with morphinan structure and opioid receptor agonist mechanism of action (substance) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Product containing codeine and paracetamol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Product containing codeine in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Product containing paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Codeine phosphate | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Codeine phosphate | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 30 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Paracetamol | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Paracetamol | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 500 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has basis of strength substance | Codeine phosphate | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 30 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Product containing codeine and paracetamol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has precise active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has precise active ingredient | Codeine phosphate | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Product containing only codeine and paracetamol in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has precise active ingredient | Codeine phosphate | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has precise active ingredient | Paracetamol | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Plays role | Antitussive therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Codeine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has active ingredient | Paracetamol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Co-codamol | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tablet.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category Schedule 5 (CD Inv) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has specific active ingredient | Codeine phosphate | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has specific active ingredient | Paracetamol | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has dispensed dose form | Tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Paracetamol+codeine phosphate 500mg/30mg tablet - product | Is a | False | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (A A H Pharmaceuticals Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (C P Pharmaceuticals Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Kapake 30mg/500mg tablets (Galen Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Zapain 30mg/500mg caplets (Goldshield Healthcare Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Kent Pharma (UK) Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Solpadol 30mg/500mg caplets (Sanofi-Synthelabo Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Zentiva Pharma UK Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Unichem Plc) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (IVAX Pharmaceuticals UK Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Sandoz Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (Kent Pharma (UK) Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Viatris UK Healthcare Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Accord Healthcare Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Teva UK Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Almus Pharmaceutical Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets 30 tablet | Is pack of | False | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets 100 tablet | Is pack of | False | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets 500 tablet | Is pack of | False | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Arrow Generics Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (Medihealth (Northern) Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Medihealth (Northern) Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Solpadol 30mg/500mg caplets (DE Pharmaceuticals) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets 100 tablet | Has VMP | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets 30 tablet | Has VMP | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets 500 tablet | Has VMP | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Phoenix Healthcare Distribution Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (Mercury Pharma Group Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Bristol Laboratories Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (Waymade Healthcare Plc) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Waymade Healthcare Plc) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (J M McGill Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (Doncaster Pharmaceuticals Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Doncaster Pharmaceuticals Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (A A H Pharmaceuticals Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (Actavis UK Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (AM Distributions (Yorkshire) Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (Phoenix Healthcare Distribution Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (M & A Pharmachem Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Sigma Pharmaceuticals Plc) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (Mawdsley-Brooks & Company Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg caplets (Wockhardt UK Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Emcozin 30mg/500mg tablets (GlucoRx Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
Co-codamol 30mg/500mg tablets (Torrent Pharma (UK) Ltd) | Is a | True | Product containing precisely codeine phosphate 30 milligram and paracetamol 500 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets